Why is Remus Pharma. falling/rising?

As of 11-Sep, Remus Pharmaceuticals Ltd is experiencing a price decline, currently at Rs 841.50, which represents a decrease of 2.15 (-0.25%). The stock has underperformed significantly, with a 1-week return of -4.70% and a year-to-date decline of -32.61%. Today's performance indicates that the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, suggesting a bearish trend. Additionally, the stock is close to its 52-week low, just 2.67% away from Rs 819. The delivery volume has also decreased by 11.02% compared to the 5-day average, indicating falling investor participation, which may contribute to the stock's downward movement.
In the broader market context, the Sensex has shown a positive return of 1.10% over the past week, contrasting sharply with Remus Pharmaceuticals' negative performance. This underperformance against the benchmark highlights the stock's struggles relative to the overall market. While the Sensex has gained 5.75% year-to-date, Remus Pharmaceuticals has faced substantial losses, further emphasizing its weak position. The lack of positive factors in the dashboard suggests that there are no significant catalysts to support a recovery in the stock's price at this time.